Upgrade to SI Premium - Free Trial

BMO Capital Upgrades Merck (MRK) to Outperform, $72 PT

August 5, 2016 12:25 PM
BMO Capital upgraded Merck (NYSE: MRK) from Market Perform to Outperform with a price target of $72.00 after Bristol ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Hot Upgrades Upgrades

Next Articles